Author

D. Miura

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

C. Kawamoto· 1 shared C. Kondo· 1 shared E. Oki· 1 shared H. Harimoto· 1 shared H. Kitao· 1 shared H. Saeki· 1 shared H. Takahashi· 1 shared K. Iwakiri· 1 shared

Activity by Year

2018-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

C. Kawamoto

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

DNA replication stress induced by trifluridine determines tumor cell fate according to p53 status

Y. Kataoka, M. Iimori, R. Fujisawa, T. Morikawa-Ichinose, S. Niimi, T. Wakasa, H. Saeki, E. Oki, D. Miura, T. Tsurimoto, Y. Maehara, H. Kitao

This paper shows that trifluridine induces DNA replication stress that leads to different cell fates in tumor cells depending on their p53 status.

bioRxiv · Sep 13, 2019Cancer Biology

Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression

T. Masu, M. Atsukawa, K. Nakatsuka, M. Shimizu, D. Miura, T. Arai, H. Harimoto, C. Kondo, K. Kaneko, S. Futagami, C. Kawamoto, H. Takahashi, K. Iwakiri

This study shows that combining anti-CD137 mAb with trastuzumab enhances NK cell-mediated ADCC against HER2-low pancreatic cancer cells, particularly in individuals with FcγRIIIA-VV/VF genotype.

bioRxiv · Jul 3, 2018Immunology